Yitzhak Shamir Medical Center

Beer Yaakov 70300

2 studies enrolling now · 3 studies all time

What they study most

Arthritis, Psoriatic, Colitis, Ulcerative, Colorectal Neoplasms, Crohn Disease

Studies at this site

• A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer — Recruiting now
• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
• A Long-term Extension Study of Ustekinumab in Pediatric Participants — Running, not enrolling